Cholesterol Education Program: Hearing Before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, First Session, December 7, 1989U.S. Government Printing Office, 1990 - 149 pages Abstract: The hearing reported in this document considered the debate over the role government should play in cholesteral education. The value of the National Heart, Lung, and Blood Institute's massive National Cholesteral Education Program in questioned and the placement of such a high priority on cholesteral education while other national health problems exist is challenged. Two witnesses testify that the hazards of cholesteral have been greatly exaggerated. Methods of cholesteral screening (public screenings vs. private visits to doctors) and their relative merits are discusses. Other witnesses assert that the dangers of cholesteral are not overstated and that the government's role in publicizing cholesteral related information will help to lower suffering and death from chronic heart disease. |
From inside the book
Results 1-5 of 52
Page 7
... cholesterol reduction tested repeatedly in elaborate clinical trials in five countries over two decades . None produced scientific evidence of having saved a single life from lowering cholesterol . The Atlantic article also reveals ...
... cholesterol reduction tested repeatedly in elaborate clinical trials in five countries over two decades . None produced scientific evidence of having saved a single life from lowering cholesterol . The Atlantic article also reveals ...
Page 10
... cholesterol reduction . The two describes the federal government's most massive trials involved screening more 15,000 suitable candidates , cost more decade to complete . than 450,000 people to identify than $ 300 million , and took ...
... cholesterol reduction . The two describes the federal government's most massive trials involved screening more 15,000 suitable candidates , cost more decade to complete . than 450,000 people to identify than $ 300 million , and took ...
Page 21
... cholesterol have been research studies where people are highly motivated ... cholesterol level of 240 or more would be considered high and anyone within 200 or 239 would be considered borderline . Do ... reduction reduce risk factors for 21.
... cholesterol have been research studies where people are highly motivated ... cholesterol level of 240 or more would be considered high and anyone within 200 or 239 would be considered borderline . Do ... reduction reduce risk factors for 21.
Page 22
... reduction reduce risk factors for heart attack ? Mr. STARE . It does if your cholesterol is 240 or above but it is doubtful if it is under that . Mr. WAXMAN . Mr. Moore , does change in diet reduce cholesterol ? Mr. MOORE . Within the ...
... reduction reduce risk factors for heart attack ? Mr. STARE . It does if your cholesterol is 240 or above but it is doubtful if it is under that . Mr. WAXMAN . Mr. Moore , does change in diet reduce cholesterol ? Mr. MOORE . Within the ...
Page 57
... cholesterol , and smoking . Several important general principles underlie these three risk factor reduction programs ; two are especially important . First , a strong science base should provide the foundation for the programs . That ...
... cholesterol , and smoking . Several important general principles underlie these three risk factor reduction programs ; two are especially important . First , a strong science base should provide the foundation for the programs . That ...
Other editions - View all
Common terms and phrases
American Heart Association atherosclerosis benefits blood cholesterol levels Blood Institute cardiovascular disease Chairman Cholesterol Education Program cholesterol lowering cholesterol measurements cholesterol reduction cholestyramine clinical trials coronary events coronary heart disease cost death dietary cholesterol drug therapy effects elderly epidemiologic studies evidence follow-up Framingham Heart Study Framingham Study Garber Testimony gemfibrozil Gotto heart attacks heart disease risk high blood cholesterol high cholesterol levels hypercholesterolemia Ischemic Heart Disease Kannel WB KUSSEROW laboratory LENFANT Lipid Lipid Research Clinics lipoprotein lower cholesterol mg/dl middle-aged million Moore myocardial infarction National Cholesterol Education National Heart NCEP guidelines NHLBI Oslo Study overall mortality patients percent physicians placebo placebo group population PUBLIC CHOLESTEROL SCREENING Public Health public screening question rates recommended reduce cholesterol regression risk of coronary risk of heart saturated fat saturated fatty acids serum cholesterol levels smoking STARE Testimony on Cholesterol total cholesterol Wagner WAXMAN WYDEN
Popular passages
Page 107 - Frick MH, Elo O, Haapa K, et al: Helsinki Heart Study: primaryprevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.
Page 46 - Institute shall collect, identify, analyze, and disseminate on a timely basis, through publications and other appropriate means, to patients, families of patients, physicians and other health professionals, and the general public, information on research, prevention, diagnosis, and treatment of heart, blood vessel, lung, and blood diseases, the maintenance of health to reduce the incidence of such diseases, and on the use of blood and blood products and the management of blood resources.
Page 135 - Canner PL, Berge KG, Wenger NK, et al. Fifteen year mortality in coronary drug project patients: longterm benefit with niacin.
Page 23 - DEPARTMENT OF HEALTH AND HUMAN SERVICES GOOD MORNING, MR. CHAIRMAN AND MEMBERS OF THE SUBCOMMITTEE. I AM RICHARD P.
Page 136 - Brunner D, Weisbort J, Meshulam N, et al. Relation of serum total cholesterol and high-density lipoprotein cholesterol percentage to the incidence of definite coronary events: twenty-year followup of the Donolo-Tel Aviv Prospective Coronary Artery Disease Study. Am J Cardiol 1987;59:1271-6.
Page 137 - Harris T, Cook EF, Kannel WB, Goldman L. Proportional hazards analysis of risk factors for coronary heart disease in individuals aged 65 or older. The Framingham Heart Study.
Page 46 - Provides leadership for a national program in diseases of the heart, blood vessels, blood, lungs, and in the use of blood and the management of blood resources.
Page 136 - Welborn TA, Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations.
Page 135 - The Prevalence of High Blood Cholesterol Levels Among Adults in the United States.
Page 100 - The differential effect of serum cholesterol, blood pressure and weight on the incidence of myocardial infarction and angina pectoris.